Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2005
10/20/2005US20050233983 Treatment of rumen acidosis with alpha-amylase inhibitors
10/20/2005US20050233969 Analogues of GLP-1
10/20/2005US20050233956 Proteins involved in the regulation of energy homeostasis
10/20/2005US20050233361 PPARdelta assay
10/20/2005US20050233328 Methods of identifying compounds that modulate protein activity
10/20/2005US20050233008 Comprehensive pharmacologic therapy for treatment of a dysfunction
10/20/2005CA2829943A1 Ion binding compositions
10/20/2005CA2806465A1 Ion binding polymers and uses thereof
10/20/2005CA2561738A1 1,3,4-oxadiazol-2-ones as ppar delta modulators_and their use thereof
10/20/2005CA2561627A1 Oxadiazolone derivatives as ppar delta agonists
10/20/2005CA2561593A1 Antiobesity drug
10/20/2005CA2561230A1 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof
10/20/2005CA2561210A1 Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments
10/20/2005CA2561162A1 Method of treating schizophrenia and/or glucoregulatory abnormalities
10/20/2005CA2560648A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/20/2005CA2559740A1 Thiadiazolidinones as gsk-3 inhibitors
10/20/2005CA2557010A1 Compounds and methods for treating dyslipidemia
10/19/2005EP1586646A2 Lawsonia intracellularis vaccine
10/19/2005EP1586641A2 Compounds for the treatment of hypercalcemia and hypocalcemia
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586319A1 Thiadiazolidinones as GSK-3 inhibitors
10/19/2005EP1586318A1 Thiadiazolidinones as GSK-3 inhibitors
10/19/2005EP1586314A1 Nateglinide tablet composition
10/19/2005EP1585959A2 Extended glucagon-like peptide-1 analogs
10/19/2005EP1585956A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2005EP1585805A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
10/19/2005EP1585733A1 Heterocyclic ppar modulators
10/19/2005EP1585726A1 Fused heterocyclic derivatives as ppar modulators
10/19/2005EP1585526A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same
10/19/2005EP1585518A2 Peptide deformylase inhibitors
10/19/2005EP1585517A1 Use of substituted 2-phenylbenzimidazoles as medicaments
10/19/2005EP1585513A1 Use of docosahexanoic acid as active substance for the treatment of lipodystrophy
10/19/2005EP1585503A2 Improved oral delivery of peptides
10/19/2005EP1487272B1 Choline-silicic acid complex with osmolytes and divalent trace elements
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1406902B1 Hexahydroazepino[4,5-g]indoles and indolines as 5-ht receptor ligands
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
10/19/2005EP1370554B1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
10/19/2005EP1345616A4 Reducing cellular damage in the human body
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1240142B1 New modulators of dopamine neurotransmission
10/19/2005EP1137635B1 N-substituted 2-cyanopyrrolidines
10/19/2005EP1075260B1 Novel fatty acid analogues for the treatment of secondary restenosis
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684954A N-substituted-2-oxodihydropyridine derivative
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1684685A Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1684669A Compositions comprising HMG-CoA reductase inhibitor
10/19/2005CN1683408A Glucagon-like peptide analog, its composition and its using method
10/19/2005CN1683360A Process for extracting folium mori flavone
10/19/2005CN1682994A Chinese medicine and its preparing method and use
10/19/2005CN1682980A Medicine for treating diabetes and its preparing method
10/19/2005CN1682941A Hyperlipemia tablet and its recipe
10/19/2005CN1682936A Medicinal composition for treating hyperlipemia and its preparing method
10/19/2005CN1682935A Quick release Yuquan micropill
10/19/2005CN1682934A Yuquan extractum and its medicine composition and use
10/19/2005CN1682933A Mai-an dripping pill for treating hyperlipoproteinemia and its preparing method
10/19/2005CN1682932A Maishu dripping pill for reducing blood fat and its preparing method
10/19/2005CN1682921A Huoliguan dripping pill for tonifying heart and kidney and its preparing method
10/19/2005CN1682910A Chinese patent medicine on health food composition and its use
10/19/2005CN1682887A Slimming and blood fat reducing preparation
10/19/2005CN1682871A Plan for producing sugar reducing coptis root pill and method for substiuting diabetic depending on western medicine
10/19/2005CN1682870A Compound capsule with omega-3 fatty acid as main component and its preparing process
10/19/2005CN1682861A Composite medicine for treating diabetes
10/19/2005CN1682854A Oral administration liquor for reducing blood fat
10/19/2005CN1682853A Sugar reducing substance extracted from soybean slag
10/19/2005CN1682837A Medicine for regulating blood fat and its preparing method
10/19/2005CN1682803A Dripping pill made from haw, chrysanthemum and Chinese wolfberry fruit and its preparing method
10/19/2005CN1682800A Medicine composition for treating hyperlipemia and its preparing method
10/19/2005CN1682797A Active source preparation and its rpeparing method
10/19/2005CN1682788A Shutongfang for killing pain and its preparation and use
10/19/2005CN1682783A Fat reducing agent
10/19/2005CN1682776A Chinese medicine preparation for treating diabetes complication and its preparing method
10/19/2005CN1682770A Process for preparing bee glue water solution and use
10/19/2005CN1682767A Pearl powder soft capsule
10/19/2005CN1682763A Method for extracting bone calcium from animal bone powder
10/19/2005CN1682760A Multiple micro element for injection and preparing method
10/19/2005CN1682740A Use of pentacylic triterpene compounds in preparing glycogenic phosphorylase inhibitor
10/19/2005CN1682737A Compound dimethylbiguanide/glipizide control release tablet and preparing method
10/19/2005CN1682713A Use of ampelopsin in preparing medicine for treating diseases related with aldose reductase
10/19/2005CN1682712A Medicinal composition for treating bone metabolic disease
10/19/2005CN1682709A Furosemide oral disintegration tablet and its preparing method
10/19/2005CN1682707A Pharmaceutical composition comprising fenofibrate and process for its preparation
10/19/2005CN1682605A Nutritive food capable of regulating blood sugar
10/19/2005CN1223672C Grifola frondosa mycelia moisture method ultra micro wall break method
10/19/2005CN1223608C Caspase-8 interacting proteins
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223371C Preparation of effective component from rhodiola crenulate and preparing method
10/19/2005CN1223368C Capsules for nourishing yin and reducing blood sugar
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223343C Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956028 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging
10/18/2005US6956026 Use of exendins for the reduction of food intake
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
1 ... 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 ... 1298